The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases
Hormone and Metabolic Research · 01.10.2024 · 56 (10) · 683-696
DOI: 10.1055/a-2266-1503 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2024. Verfasst von Meng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Obesity, Atherosclerosis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 185 Literaturangaben.
Abstract (Originalsprache)
Obesity, non-alcoholic fatty liver disease (NAFLD), and atherosclerotic cardiovascular diseases are common and growing public health concerns. Previous epidemiological studies unfolded the robust correlation between obesity, NAFLD, and atherosclerotic cardiovascular diseases. Obesity is a well-known risk factor for NAFLD, and both of them can markedly increase the odds of atherosclerotic cardiovascular diseases. On the other hand, significant weight loss achieved by lifestyle modification, bariatric surgery, or medications, such as semaglutide, can concomitantly improve NAFLD and atherosclerotic cardiovascular diseases. Therefore, certain pathophysiological links are involved in the development of NAFLD in obesity, and atherosclerotic cardiovascular diseases in obesity and NAFLD. Moreover, recent studies indicated that simultaneously targeting several mechanisms by tirzepatide and retatrutide leads to greater weight loss and markedly improves the complications of metabolic syndrome. These findings remind the importance of a mechanistic viewpoint for breaking the association between obesity, NAFLD, and atherosclerotic cardiovascular diseases. In this review article, we mainly focus on shared pathophysiological mechanisms, including insulin resistance, dyslipidemia, GLP1 signaling, inflammation, oxidative stress, mitochondrial dysfunction, gut dysbiosis, renin-angiotensin-aldosterone system (RAAS) overactivity, and endothelial dysfunction. Most of these pathophysiological alterations are primarily initiated by obesity. The development of NAFLD further exacerbates these molecular and cellular alterations, leading to atherosclerotic cardiovascular disease development or progression as the final manifestation of molecular perturbation. A better insight into these mechanisms makes it feasible to develop new multi-target approaches to simultaneously unhinge the deleterious chain of events linking obesity and NAFLD to atherosclerotic cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Clinical Specialty of Integrated Chinese and Western Medicine, The First Clinical School of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Pharmacology, Babol University of Medical Science, Babol, Iran.
- Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Yunsheng Xu
Zitieren
APA
Li, M., Cui, M., Li, G., Liu, Y., Xu, Y., Eftekhar, S. P., & Ala, M. (2024). The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. Hormone and Metabolic Research, 56(10), 683-696. https://doi.org/10.1055/a-2266-1503
Vancouver
Li M, Cui M, Li G, Liu Y, Xu Y, Eftekhar SP, et al. The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. Hormone and Metabolic Research. 2024;56(10):683-696. doi:10.1055/a-2266-1503
BibTeX
@article{Li2024,
author = {Li, Meng and Cui, Man and Li, Guoxia and Liu, Yueqiu and Xu, Yunsheng and Eftekhar, Seyed Parsa and Ala, Moein},
title = {The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {10},
pages = {683--696},
doi = {10.1055/a-2266-1503}
}
EUVIMED